menu

ASCVD Risk Reduction in Patients With T2D

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

ASCVD Risk Reduction in Patients With T2D

Details
Recommended

Overview

ReachMD Healthcare Image
RestartResume

What should your care plan for patients with T2D with an established risk of ASCVD look like? Find out in this virtual simulation.

  • Sponsored by

  • Overview

    Meet Leon and Tami, two hypothetical patients with type 2 diabetes (T2D) and an established risk of atherosclerotic cardiovascular disease (ASCVD). Test your management approach and see how it compares to the latest American Diabetes Association’s Standards of Care in Diabetes with this virtual simulation.

    Novo Nordisk is a registered trademark of Novo Nordisk A/S.
    © 2023 Novo Nordisk All rights reserved.
    US23DI00180 August 2023

Schedule18 Jul 2024